Mutational Landscape of DNA Damage Response Pathways in Kazakhstani Children with Medulloblastoma
Background.Medulloblastoma (MB) is the most common malignant pediatric brain tumor, and alterations in DNA damage response (DDR) genes may influence tumorigenesis, treatment response, and prognosis. However, the landscape of DDR mutations in Central Asian pediatric populations remains unexplored.Methods.We performed a retrospective analysis of 42 pediatric MB samples collected from the “University Medical Center” Corporate Fund (Kazakhstan) between 2015 and 2024. DNA extracted from formalin-fixed paraffin-embedded (FFPE) tumor tissues underwent whole-exome sequencing with targeted analysis of 52 DDR pathway genes. Variants were classified per ACMG guidelines, and correlations with clinical data were evaluated. Results.Pathogenic or likely pathogenic DDR gene mutations were identified in 71.4% of cases, with a predominance of homologous recombination (HR) and mismatch repair (MMR) pathway alterations. Frameshift and nonsense mutations were the most frequent types. Commonly mutated genes included ERCC6, SLX4, FANCM, and PMS1. Functional sensitivity analysis suggested that HR and nucleotide excision repair (NER) pathway mutations may confer increased susceptibility to cisplatin and etoposide. No significant associations were found between DDR status and survival or tumor stage overall; however, the total number of DDR variants negatively correlated with tumor stage (r = -0.436, p = 0.019), and translesion synthesis (TLS) pathway variants correlated positively with metastasis (r = 0.346, p = 0.045).Conclusions.This study demonstrates a high prevalence of DDR gene mutations among pediatric MB patients, highlighting the potential clinical relevance of DDR alterations for risk stratification and personalized therapeutic strategies. The findings support the integration of DDR profiling into future MB research and treatment planning. Keywords: medulloblastoma,DNA damage response,pediatric brain tumor,mutations,precision medicine.
Сведения
- Журнал
- Astana Medical Journal
- Опубликовано
- 2025 · Т. 125, № 4, С. amj001
- Язык
- Английский
- ISSN
- 1562-2940 · 2790-1203
- Издатель
- NpJSC "Astana Medical University